Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
vnaprej opredeljena meja neinferiornosti za razliko zdravljenj je bila 20 %.
the prespecified non-inferiority margin for the treatment difference was 20%.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ap<0,0001 za oceno neinferiornosti v primerjavi s shemo pro re nata
ap<0.0001 for assessment of non-inferiority to prn
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
opravili so analizo neinferiornosti za pfs in os ob vnaprej določeni meji neinferiornosti 15 %.
a non-inferiority analysis was conducted for pfs and os, with a pre-specified non-inferiority margin of 15%.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
#dokaz neinferiornosti zahteva, da je spodnja meja 95 % iz gmp razmerja večja od 0,67.
#demonstration of non-inferiority required that the lower bound of the 95% ci of the gmt ratio be greater than 0.67.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
primerjava srednje spremembe vrednosti očesnega tlaka čez dan (mmhg) glede na začetne vednosti – študija neinferiornosti
comparison of mean diurnal iop (mmhg) change from baseline– non-inferiority study
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Študiji so končali po primarni analizi učinkovitosti 24. teden, ker nista pokazali neinferiornosti raltegravirja v primerjavi z lopinavirjem (+) ritonavirjem.
these studies were terminated after the primary efficacy analysis at week 24 because they failed to demonstrate non-inferiority of raltegravir versus lopinavir (+) ritonavir.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
odmerki dolgodelujočega parantertalnega aripiprazola 50 mg/25 mg so bili vključeni kot nizki odmerki aripiprazola, da bi preizkusili občutljivost analize pri dokazovanju neinferiornosti zdravila.
the aripiprazole long-acting injectable 50 mg/25 mg dose was included as a low dose aripiprazole to test assay sensitivity for the non-inferiority design.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ta študija ni dokazala ne superiornosti ne neinferiornosti optimizirane osnovne terapije same, čeprav ni bilo neželenih izidov, kar zadeva virusno breme ali število celic cd4+.
62%
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
o učinkovitosti cepiva so sklepali na podlagi dokaza imunološke neinferiornosti (temelječ na primerjavi razmerij titrov rsba vsaj 8) v primerjavi z odobrenimi cepivi proti meningokokom.
vaccine efficacy was inferred from the demonstration of immunologic non inferiority (based mainly on comparing proportions with rsba titres at least 8) to licensed meningococcal vaccines.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
učinkovitost zonisamida kot monoterapije so dokazali v dvojno slepi primerjavi neinferiornosti z vzporednimi skupinami s karbamazepinom s podaljšanim sproščanjem pri 583 odraslih osebah z na novo diagnosticiranimi parcialnimi epileptičnimi napadi s sekundarno generaliziranimi tonično- klonični napadi ali brez njih.
efficacy of zonisamide as monotherapy was established in a double-blind, parallel group, non- inferiority comparison to carbamazepine prolonged release (pr) in 583 adult subjects with newly diagnosed partial seizures with or without secondary generalised tonic-clonic seizures.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
po 26 tednih je bila razlika hba1c med zdravljenjema za zdravilo eperzan in insulin lispro 0,2 % in je dosegla vnaprej opredeljeno mejo neinferiornosti (0,4 %).
at 26 weeks, the between-treatment difference in hba1c of 0.2% for eperzan and insulin lispro met the pre-specified noninferiority margin (0.4%).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
v primarni analizi učinkovitosti, globalnem odzivu populacij mitt na koncu intravenskega zdravljenja, so anidulafungin in flukonazol primerjali z vnaprej opredeljeno dvostopenjsko statistično primerjavo (neinferiornosti in zatem superiornosti).
in the primary efficacy analysis, global response in the mitt populations at the end of intravenous therapy, anidulafungin was compared to fluconazole in a pre-specified two- step statistical comparison (non-inferiority followed by superiority).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
95 % iz (-5,26, 3,99) za razliko v ocenjenem razmerju bolnikov, pri katerih se do konca 26. tedna pojavijo znaki bližnjega relapsa bolezni, izključuje predhodno opredeljeno mejo neinferiornosti, ki znaša 11,5 %.
the 95 % ci (-5.26, 3.99) for the difference in the estimated proportion of patients experiencing impending relapse by end of week 26 excluded the predefined non-inferiority margin, 11.5 %.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: